Literature DB >> 5050211

Calcitonin treatment in Ekman-Lobstein disease.

A Caniggia, C Gennari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5050211     DOI： 10.1007/bf02061963

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN： 0008-0594


× No keyword cloud information.
  3 in total

1.  Fragilitas ossium hereditaria tarda: Ekman-Lobstein disease.

Authors:  A CANIGGIA; C STUART; R GUIDERI
Journal:  Acta Med Scand Suppl       Date:  1958

2.  [Glycosaminoglycan and collagen analyses in osteogenesis imperfecta].

Authors:  H Bleckmann; H Kresse; J Wollensak; E Buddecke
Journal:  Z Kinderheilkd       Date:  1971

3.  Calcium metabolism and 47calcium kinetics before and after long-term thyrocalcitonin treatment in senile osteoporosis.

Authors:  A Caniggia; C Gennari; M Bencini; L Cesari; G Borrello
Journal:  Clin Sci       Date:  1970-04       Impact factor: 6.124
  3 in total
  2 in total

1.  Calcitonin in osteogenesis imperfecta.

Authors:  R Smith; M J Francis; R G Russel
Journal:  Br Med J       Date:  1973-04-14

Review 2.  Pharmacology and therapeutic use of calcitonin.

Authors:  J C Stevenson; I M Evans
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.